Skip to main content
Top
Published in: Journal of Nephrology 1/2020

Open Access 01-02-2020 | Anemia | Original Article

Anemia and clinical outcomes in patients with non-dialysis dependent or dialysis dependent severe chronic kidney disease: a Danish population-based study

Authors: Gunnar Toft, Uffe Heide-Jørgensen, Heleen van Haalen, Glen James, Katarina Hedman, Henrik Birn, Christian F. Christiansen, Reimar W. Thomsen

Published in: Journal of Nephrology | Issue 1/2020

Login to get access

Abstract

Background

Routine clinical evidence is limited on clinical outcomes associated with anemia in patients with severe chronic kidney disease (CKD).

Methods

We linked population-based medical databases to identify individuals with severe CKD (eGFR < 30 mL/min/1.73 m2) in Northern Denmark from 2000 to 2016, including prevalent patients as of 1 January 2009 or incident patients hereafter into the study. We classified patients as non-anemic (≥ 12/≥ 13 g/dl hemoglobin (Hgb) in women/men), anemia grade 1 (10–12/13 g/dl Hgb in women/men), 2 (8–10 g/dl Hgb), and 3+ (< 8 g/dl Hgb), allowing persons to contribute with patient profiles and risk time in consecutively more severe anemia grade cohorts. Patients were stratified by dialysis status and followed for clinical outcomes.

Results

We identified 16,972 CKD patients contributing with a total of 28,510 anemia patient profiles, of which 3594 had dialysis dependent (DD) and 24,916 had non-dialysis dependent (NDD) severe CKD. Overall, 14% had no anemia, 35% grade 1 anemia, 44% grade 2 anemia and 17% grade 3+ anemia. Compared to patients with no anemia, adjusted hazard ratios (HRs) for NDD patients with grade 3+ anemia were elevated for incident dialysis (1.91, 95% CI 1.61–2.26), any acute hospitalization (1.74, 95% CI 1.57–1.93), all-cause death (1.82, 95% CI 1.70–1.94), and MACE (1.14, 95% CI 1.02–1.26). Similar HRs were observed among DD patients.

Conclusions

Among NDD or DD patients with severe CKD, presence and severity of anemia were associated with increased risks of incident dialysis for NDD patients and with acute hospitalizations, death and MACE for all patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Stauffer ME, Fan T (2014) Prevalence of anemia in chronic kidney disease in the United States. PLoS One 9:e84943CrossRef Stauffer ME, Fan T (2014) Prevalence of anemia in chronic kidney disease in the United States. PLoS One 9:e84943CrossRef
2.
go back to reference Nolan KA, Wenger RH (2018) Source and microenvironmental regulation of erythropoietin in the kidney. Curr Opin Nephrol Hypertens 27:277–282CrossRef Nolan KA, Wenger RH (2018) Source and microenvironmental regulation of erythropoietin in the kidney. Curr Opin Nephrol Hypertens 27:277–282CrossRef
3.
go back to reference Shih HM, Wu CJ, Lin SL (2018) Physiology and pathophysiology of renal erythropoietin-producing cells. J Formos Med Assoc = Taiwan yi zhi 117:955–963CrossRef Shih HM, Wu CJ, Lin SL (2018) Physiology and pathophysiology of renal erythropoietin-producing cells. J Formos Med Assoc = Taiwan yi zhi 117:955–963CrossRef
4.
5.
go back to reference Thorp ML, Johnson ES, Yang X, Petrik AF, Platt R, Smith DH (2009) Effect of anaemia on mortality, cardiovascular hospitalizations and end-stage renal disease among patients with chronic kidney disease. Nephrology 14:240–246CrossRef Thorp ML, Johnson ES, Yang X, Petrik AF, Platt R, Smith DH (2009) Effect of anaemia on mortality, cardiovascular hospitalizations and end-stage renal disease among patients with chronic kidney disease. Nephrology 14:240–246CrossRef
6.
go back to reference Stevens LA, Viswanathan G, Weiner DE (2010) Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future projections, and clinical significance. Adv Chronic Kidney Dis 17:293–301CrossRef Stevens LA, Viswanathan G, Weiner DE (2010) Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future projections, and clinical significance. Adv Chronic Kidney Dis 17:293–301CrossRef
7.
go back to reference Yamamoto T, Miyazaki M, Nakayama M, Yamada G, Matsushima M, Sato M et al (2016) Impact of hemoglobin levels on renal and non-renal clinical outcomes differs by chronic kidney disease stages: the Gonryo study. Clin Exp Nephrol 20:595–602CrossRef Yamamoto T, Miyazaki M, Nakayama M, Yamada G, Matsushima M, Sato M et al (2016) Impact of hemoglobin levels on renal and non-renal clinical outcomes differs by chronic kidney disease stages: the Gonryo study. Clin Exp Nephrol 20:595–602CrossRef
8.
go back to reference Keane WF, Brenner BM, de Zeeuw D, Grunfeld JP, McGill J, Mitch WE et al (2003) The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study. Kidney Int 63:1499–1507CrossRef Keane WF, Brenner BM, de Zeeuw D, Grunfeld JP, McGill J, Mitch WE et al (2003) The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study. Kidney Int 63:1499–1507CrossRef
9.
go back to reference Abramson JL, Jurkovitz CT, Vaccarino V, Weintraub WS, McClellan W (2003) Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study. Kidney Int 64:610–615CrossRef Abramson JL, Jurkovitz CT, Vaccarino V, Weintraub WS, McClellan W (2003) Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study. Kidney Int 64:610–615CrossRef
10.
go back to reference Weiner DE, Tighiouart H, Vlagopoulos PT, Griffith JL, Salem DN, Levey AS et al (2005) Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease. JASN 16:1803–1810CrossRef Weiner DE, Tighiouart H, Vlagopoulos PT, Griffith JL, Salem DN, Levey AS et al (2005) Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease. JASN 16:1803–1810CrossRef
11.
go back to reference Levin A, Djurdjev O, Duncan J, Rosenbaum D, Werb R (2006) Haemoglobin at time of referral prior to dialysis predicts survival: an association of haemoglobin with long-term outcomes. Nephrol Dial Transplant 21:370–377CrossRef Levin A, Djurdjev O, Duncan J, Rosenbaum D, Werb R (2006) Haemoglobin at time of referral prior to dialysis predicts survival: an association of haemoglobin with long-term outcomes. Nephrol Dial Transplant 21:370–377CrossRef
12.
go back to reference Kovesdy CP, Trivedi BK, Kalantar-Zadeh K, Anderson JE (2006) Association of anemia with outcomes in men with moderate and severe chronic kidney disease. Kidney Int 69:560–564CrossRef Kovesdy CP, Trivedi BK, Kalantar-Zadeh K, Anderson JE (2006) Association of anemia with outcomes in men with moderate and severe chronic kidney disease. Kidney Int 69:560–564CrossRef
13.
go back to reference Yotsueda R, Tanaka S, Taniguchi M, Fujisaki K, Torisu K, Masutani K et al (2018) Hemoglobin concentration and the risk of hemorrhagic and ischemic stroke in patients undergoing hemodialysis: the Q-cohort study. Nephrol Dial Transplant 33:856–864CrossRef Yotsueda R, Tanaka S, Taniguchi M, Fujisaki K, Torisu K, Masutani K et al (2018) Hemoglobin concentration and the risk of hemorrhagic and ischemic stroke in patients undergoing hemodialysis: the Q-cohort study. Nephrol Dial Transplant 33:856–864CrossRef
14.
go back to reference Phrommintikul A, Haas SJ, Elsik M, Krum H (2007) Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet 369:381–388CrossRef Phrommintikul A, Haas SJ, Elsik M, Krum H (2007) Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet 369:381–388CrossRef
15.
go back to reference Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU et al (2009) A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 361:2019–2032CrossRef Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU et al (2009) A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 361:2019–2032CrossRef
16.
go back to reference Mc Causland FR, Claggett B, Burdmann EA, Chertow GM, Cooper ME, Eckardt KU et al (2019) Treatment of anemia with darbepoetin prior to dialysis initiation and clinical outcomes: analyses from the trial to reduce cardiovascular events with aranesp therapy (TREAT). Am J Kidney Dis 73:309–315CrossRef Mc Causland FR, Claggett B, Burdmann EA, Chertow GM, Cooper ME, Eckardt KU et al (2019) Treatment of anemia with darbepoetin prior to dialysis initiation and clinical outcomes: analyses from the trial to reduce cardiovascular events with aranesp therapy (TREAT). Am J Kidney Dis 73:309–315CrossRef
17.
go back to reference Park H, Liu X, Henry L, Harman J, Ross EA (2018) Trends in anemia care in non-dialysis-dependent chronic kidney disease (CKD) patients in the United States (2006–2015). BMC Nephrol 19:318CrossRef Park H, Liu X, Henry L, Harman J, Ross EA (2018) Trends in anemia care in non-dialysis-dependent chronic kidney disease (CKD) patients in the United States (2006–2015). BMC Nephrol 19:318CrossRef
18.
go back to reference Stivelman JC (2017) Target-based anemia management with erythropoiesis stimulating agents (risks and benefits relearned) and iron (still more to learn). Semin Dial 30:142–148CrossRef Stivelman JC (2017) Target-based anemia management with erythropoiesis stimulating agents (risks and benefits relearned) and iron (still more to learn). Semin Dial 30:142–148CrossRef
19.
go back to reference Grann AF, Erichsen R, Nielsen AG, Froslev T, Thomsen RW (2011) Existing data sources for clinical epidemiology: the clinical laboratory information system (LABKA) research database at Aarhus University, Denmark. Clin Epidemiol 3:133–138CrossRef Grann AF, Erichsen R, Nielsen AG, Froslev T, Thomsen RW (2011) Existing data sources for clinical epidemiology: the clinical laboratory information system (LABKA) research database at Aarhus University, Denmark. Clin Epidemiol 3:133–138CrossRef
20.
go back to reference Ehrenstein V, Antonsen S, Pedersen L (2010) Existing data sources for clinical epidemiology: aarhus University Prescription Database. Clin Epidemiol 2:273–279CrossRef Ehrenstein V, Antonsen S, Pedersen L (2010) Existing data sources for clinical epidemiology: aarhus University Prescription Database. Clin Epidemiol 2:273–279CrossRef
21.
go back to reference Pottegard A, Schmidt SAJ, Wallach-Kildemoes H, Sorensen HT, Hallas J, Schmidt M (2017) Data resource profile: the Danish national prescription registry. Int J Epidemiol 46:798PubMed Pottegard A, Schmidt SAJ, Wallach-Kildemoes H, Sorensen HT, Hallas J, Schmidt M (2017) Data resource profile: the Danish national prescription registry. Int J Epidemiol 46:798PubMed
22.
go back to reference Levey AS, Greene T, Kusek JW, Beck GJ (2000) A simplified equation to predict glomerular filtration rate from serum creatinine. JASN. 2000(11):155A Levey AS, Greene T, Kusek JW, Beck GJ (2000) A simplified equation to predict glomerular filtration rate from serum creatinine. JASN. 2000(11):155A
23.
go back to reference KDIGO (2012) Chapter 1: diagnosis and evaluation of anemia in CKD. Kidney Int Suppl 2:288–291CrossRef KDIGO (2012) Chapter 1: diagnosis and evaluation of anemia in CKD. Kidney Int Suppl 2:288–291CrossRef
24.
go back to reference Lin DY, Wei LJ (1989) The robust inference for the cox proportional hazards model. J Am Stat Assoc 84:1074–1078CrossRef Lin DY, Wei LJ (1989) The robust inference for the cox proportional hazards model. J Am Stat Assoc 84:1074–1078CrossRef
25.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRef
26.
go back to reference Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sorensen HT (2015) The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol 7:449–490CrossRef Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sorensen HT (2015) The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol 7:449–490CrossRef
27.
go back to reference Sundboll J, Adelborg K, Munch T, Froslev T, Sorensen HT, Botker HE et al (2016) Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study. BMJ Open 6:e012832CrossRef Sundboll J, Adelborg K, Munch T, Froslev T, Sorensen HT, Botker HE et al (2016) Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study. BMJ Open 6:e012832CrossRef
28.
go back to reference Levey AS, Inker LA, Coresh J (2014) GFR estimation: from physiology to public health. Am J Kidney Dis 63:820–834CrossRef Levey AS, Inker LA, Coresh J (2014) GFR estimation: from physiology to public health. Am J Kidney Dis 63:820–834CrossRef
29.
30.
go back to reference Mikhail A, Brown C, Williams JA, Mathrani V, Shrivastava R, Evans J et al (2017) Renal association clinical practice guideline on Anaemia of chronic kidney disease. BMC Nephrol 18:345CrossRef Mikhail A, Brown C, Williams JA, Mathrani V, Shrivastava R, Evans J et al (2017) Renal association clinical practice guideline on Anaemia of chronic kidney disease. BMC Nephrol 18:345CrossRef
Metadata
Title
Anemia and clinical outcomes in patients with non-dialysis dependent or dialysis dependent severe chronic kidney disease: a Danish population-based study
Authors
Gunnar Toft
Uffe Heide-Jørgensen
Heleen van Haalen
Glen James
Katarina Hedman
Henrik Birn
Christian F. Christiansen
Reimar W. Thomsen
Publication date
01-02-2020
Publisher
Springer International Publishing
Published in
Journal of Nephrology / Issue 1/2020
Print ISSN: 1121-8428
Electronic ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-019-00652-9

Other articles of this Issue 1/2020

Journal of Nephrology 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.